−3.3205 EUR
−8.74 M EUR
533.41 K EUR
About NEOVACS
Sector
CEO
Hugo Brugière
Headquarters
Suresnes
Website
Founded
1992
ISIN
FR001400MV37
FIGI
BBG000KB5596
Neovacs SA is a biotechnology company focused on therapeutic vaccines targeting the treatment of autoimmune diseases. The firm is developing a product portfolio using its Kinoid technology through self-antigens, which cause autoimmune or inflammatory diseases. Its product portfolio includes IFNa kinoid, IL-4/13 kinoid, and IgE kinoid. The company was founded by Daniel Zagury on April 16, 1993 and is headquartered in Paris, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALNEV is 0.0002 EUR — it has decreased by −33.33% in the past 24 hours. Watch NEOVACS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange NEOVACS stocks are traded under the ticker ALNEV.
ALNEV stock hasn't changed in a week, the month change is a −33.33% fall, over the last year NEOVACS has showed a −99.99% decrease.
ALNEV reached its all-time high on Dec 29, 2022 with the price of 824,000.0000 EUR, and its all-time low was 0.0001 EUR and was reached on Nov 13, 2024. View more price dynamics on ALNEV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALNEV stock is 50.00% volatile and has beta coefficient of 1.85. Track NEOVACS stock price on the chart and check out the list of the most volatile stocks — is NEOVACS there?
Yes, you can track NEOVACS financials in yearly and quarterly reports right on TradingView.
ALNEV net income for the last half-year is −30.99 M EUR, while the previous report showed −4.46 M EUR of net income which accounts for −594.80% change. Track more NEOVACS financial stats to get the full picture.
No, ALNEV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEOVACS EBITDA is −6.75 M EUR, and current EBITDA margin is −1.26 K%. See more stats in NEOVACS financial statements.
Like other stocks, ALNEV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEOVACS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEOVACS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEOVACS stock shows the sell signal. See more of NEOVACS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.